Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Radiation
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseRadiationC57BL/6 wild typeIntraperitoneal10 microM CD47 morpholino in a 750 microlitre volume of sal…Pre-treatment arm dosed 48 h before irradiation; post-treatment arm dosed immed…
Model: Single dose total body irradiation of 7.6 Gy X-rays (300 kVp, 2.0 mm aluminium filtration) at 2.53 Gy/min; a separate arm used 7.6 Gy hindlimb irradiation
Pre-treatment with CD47 morpholino raised 30-day survival to 71.5 percent versus 21.4 percent for saline and 40 percent for mismatched morpholino, preserved bone marrow proliferative capacity and circulating lymphocytes and reduced gastrointestinal apoptosis.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.